EUVIMEDEUVIMED entdecken
Open Access

End-Organ Damage Associated With Primary Hyperparathyroidism

Lia D Delaney, Heather S Day, Katherine D Arnow, Rozalina G McCoy, Juan P Brito, Electron Kebebew, Carolyn D Seib

JAMA Surgery · 2026

DOI: 10.1001/jamasurg.2026.3051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, 2026. Verfasst von Lia D Delaney und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stanford-Surgery Policy Improvement Research and Education Center (S-SPIRE), Department of Surgery, Stanford University School of Medicine, Palo Alto…. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Osteoporosis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Primary hyperparathyroidism (PHPT) is common and contributes to skeletal and kidney end-organ damage. Although parathyroidectomy can mitigate these complications, many patients are managed with observation, and real-world data on the population-based frequency and timing of end-organ damage under usual care are limited.

Objective

To evaluate the frequency and timing of end-organ damage associated with PHPT. Design, Setting, and Participants This cohort study included a population-based cohort identified from national electronic health record (EHR) and claims data (2010-2023) with follow-up through 2023. Participants were adults with a new biochemical diagnosis of PHPT. Data analysis was performed from August 2025 to April 2026. Exposure A new biochemical diagnosis of PHPT was defined as an elevated PTH (>65 pg/mL) within 1 month after a second elevated calcium level (serum calcium >10.2 mg/dL or ionized calcium >1.3 mmol/L or >5.3 mg/dL). Main Outcomes and Measures PHPT-associated end-organ damage (osteoporosis, atraumatic fractures, kidney stones, stage 3 or worse chronic kidney disease) at or after PHPT diagnosis using EHR or claim codes and laboratory data, in addition to the frequency and timing of parathyroidectomy.

Results

A total of 43 399 patients with PHPT were identified (mean [SD] age, 67.9 [12.5] years; 33 854 [78%] female and 9545 [22%] male), of whom 22 279 (51.3%) had end-organ damage at diagnosis. Among 21 120 patients without end-organ damage at diagnosis, 6762 (32.0%) progressed to end-organ damage after a median (IQR) 516 (166-1125) days. Only 4442 patients (19.9%) with end-organ damage at diagnosis were treated with parathyroidectomy. Among those who progressed to end-organ damage, 1348 (19.9%) underwent subsequent parathyroidectomy, which occurred a median (IQR) 154 (41-439) days later. Conclusions and Relevance In this national cohort of adults with a biochemical diagnosis of PHPT, 67% had PHPT-associated end-organ damage at diagnosis or on follow-up. Despite this, parathyroidectomy was uncommon. These findings may inform strategies to optimize utilization of parathyroidectomy and mitigate PHPT-associated morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryOsteoporosisRenal Insufficiency, ChronicHumansFemaleMaleMiddle AgedAgedParathyroidectomyCalciumParathyroid HormoneFractures, SpontaneousKidney CalculiCohort Studies

Substanzen

CalciumParathyroid Hormone

Autor:innen und Institutionen

  • Stanford-Surgery Policy Improvement Research and Education Center (S-SPIRE), Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
  • Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore.
  • University of Maryland Institute for Health Computing, North Bethesda.
  • Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Division of General Surgery, Palo Alto Veterans Affairs Health Care System, Palo Alto, California.

Förderung

  • NIA NIH HHS

Zitieren

APA

Delaney, L. D., Day, H. S., Arnow, K. D., McCoy, R. G., Brito, J. P., Kebebew, E., & Seib, C. D. (2026). End-Organ Damage Associated With Primary Hyperparathyroidism. JAMA Surgery. https://doi.org/10.1001/jamasurg.2026.3051

Vancouver

Delaney LD, Day HS, Arnow KD, McCoy RG, Brito JP, Kebebew E, et al. End-Organ Damage Associated With Primary Hyperparathyroidism. JAMA Surgery. 2026. doi:10.1001/jamasurg.2026.3051

BibTeX
@article{Delaney2026,
  author = {Delaney, Lia D and Day, Heather S and Arnow, Katherine D and McCoy, Rozalina G and Brito, Juan P and Kebebew, Electron and Seib, Carolyn D},
  title = {End-Organ Damage Associated With Primary Hyperparathyroidism},
  journal = {JAMA Surgery},
  year = {2026},
  doi = {10.1001/jamasurg.2026.3051}
}
Kostenlos starten →